PELLETIER SAUNDRA L 4
4 · Evofem Biosciences, Inc. · Filed Feb 23, 2022
Insider Transaction Report
Form 4
PELLETIER SAUNDRA L
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2022-02-18+750,000→ 1,435,837 total - Award
Stock option (right to buy)
2022-02-18+750,000→ 750,000 totalExercise: $0.49Exp: 2032-02-18→ Common Stock (750,000 underlying)
Footnotes (2)
- [F1]The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2022.
- [F2]The shares of common stock exercisable pursuant to the option will vest in a series of forty-eight (48) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from February 18, 2022.